Publikationen der ALS-Forschungsgruppe an der Charité
Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial
Maier A, Holm T, Wicks P, Steinfurth L, Linke P, Münch C,
Motor neuron diseases
Petri S, Meyer T. Motoneuronerkrankungen. Familiäre ALS, SMA, HMN Familial ALS, SMA
Heterozygous S44L missense change of the spastin gene in amyotrophic lateral sclerosis
Münch C, Rolfs A, Meyer T. Heterozygous S44L missense change of the
Elective termination of respiratory therapy in amyotrophic lateral sclerosis
Meyer T, Dullinger JS, Münch C, Keil JP, Hempel E, Rosseau S,
Thalidomide causes sinus bradycardia in ALS
Meyer T, Maier A, Borisow N, Dullinger JS, Splettstösser G, Ohlraun S,
Progressive muscle atrophy. A rarely diagnosed variant of amyotrophic lateral sclerosis
Meyer T, Münch C, van Landeghem FK, Borisow N, Dullinger J, Linke
Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité
Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis
Ludolph AC, Dorst J, Dreyhaupt J,
Prognostic factors in ALS: a comparison between Germany and China
Dorst J, Chen L, Rosenbohm A,
GABA B receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis
Schumacher H, Meyer T, Prüss H.
Comprehensive analysis of the mutation spectrum in 301 German ALS families
Müller K, Brenner D, Weydt P,
Therapeutic decision in ALS patients: cross-cultural differences and clinical implications
Andersen PM, Kuzma-Kozakiewicz M, Keller J,
The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy
Rosenbohm A, Hirsch S, Volk AE,
Hot-spot KIF5A mutations cause familial ALS
Brenner D, Yilmaz R, Müller K,
July 2017 ENCALS statement on edaravone
Al-Chalabi A, Andersen PM, Chandran S,
Genome-wide association analysis identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
van Rheenen W, Shatunov A, Dekker
